AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CLORAZEPATE DIPOTASSIQUE

11 registrations across 3 African markets— 9 active

Markets with CLORAZEPATE DIPOTASSIQUE

Recent registrations

Brand / ProductMarketHolderStatusExpires
TRANXENE
Gélule / 10 MG
🇹🇳TunisiaSANOFI-AVENTIS FRANCEexpiredMay 1995
TRANXENE
Pdre p.prep.injectable / 20 MG
🇹🇳TunisiaSANOFI-AVENTIS FRANCEexpiredMay 1995
TRANXENE 10 GELU BTE(3 X 10) SANOFI-AVENTIS France
gélule, Boîte de 3 blisters de
🇲🇬MadagascarSANOFI WINTHROP INDUSTRIE,,active
TRANXENE 5 GELU BTE(3 X 10) SANOFI-AVENTIS France
gélule, Boîte de 3 blisters de
🇲🇬MadagascarSANOFI WINTHROP INDUSTRIE,,active
TRANXENE
gélule / 10mg
🇸🇳SenegalSANOFIactive
TRANXENE 10 GELU BTE(3 X 10) SANOFI-AVENTIS France
gélule, Boîte de 3 blisters de
🇲🇬MadagascarSANOFI WINTHROP INDUSTRIE,,active
TRANXENE 5 GELU BTE(3 X 10) SANOFI-AVENTIS France
gélule, Boîte de 3 blisters de
🇲🇬MadagascarSANOFI WINTHROP INDUSTRIE,,active
CLORAXENE
gélule / 5 mg
🇸🇳SenegalSALEMactive
TRANXENE
gélule / 10mg
🇸🇳SenegalSANOFIactive
TRANXENE
comprimé / 5mg
🇸🇳SenegalSANOFIactive
TRANXENE
comprimé / 5mg
🇸🇳SenegalSANOFIactive

CLORAZEPATE DIPOTASSIQUE in Africa — Regulatory Overview

CLORAZEPATE DIPOTASSIQUE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Madagascar, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 9 (82%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.